| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/26/2001 | CN1327976A Benzoxazinone compounds asymmetrically synthesized from new intermediate |
| 12/26/2001 | CN1327853A Stable alpha-interferon preparation |
| 12/26/2001 | CN1327851A Caspule for dispelling wind and detoxicating body |
| 12/26/2001 | CN1327850A American ginseng extract (CNT-2000) without residual agricultural chemical and its usage |
| 12/26/2001 | CN1327793A Pyrrolo-triazine and pyrimidine compounds |
| 12/26/2001 | CN1076624C Nasally administrable compositions |
| 12/26/2001 | CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters |
| 12/26/2001 | CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 12/25/2001 | US6333410 Process for the preparation and purification of thiol-containing maytansinoids |
| 12/25/2001 | US6333343 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333325 Method of treating cytokine mediated diseases or conditions |
| 12/25/2001 | US6333323 Indole derivatives with antiviral activity |
| 12/25/2001 | US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis |
| 12/25/2001 | US6333171 CD4 gene regulatory sequences specifically expressed in mature T cells |
| 12/25/2001 | US6333041 Nontoxic vernix compositions and method of producing |
| 12/25/2001 | US6333038 Administering to an individual who has not been sensitized by environmental allergen a dose and form of allergen to induce estabilishment of stable population of allergen-specific t-helper-1-like memory lymphocytes |
| 12/25/2001 | US6333036 Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 12/25/2001 | US6333035 Administering monoclonal antibody against a human t-cell leukemia virus-derived transcription activating factor p40tax-induced cell membrane glycoprotein of 34 kda (gp34) in an amount effective for treating rheumatoid arthritis |
| 12/25/2001 | US6333034 Administering anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product |
| 12/25/2001 | US6333033 Autoantibody inhibitors |
| 12/25/2001 | CA2186775C Ribosome fraction and composition containing the same |
| 12/20/2001 | WO2001096567A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/20/2001 | WO2001096565A2 Binding agents: chimeric ligand/receptor proteins |
| 12/20/2001 | WO2001096564A2 Hla-g (hla-g7) isoform and its applications |
| 12/20/2001 | WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same |
| 12/20/2001 | WO2001096553A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096534A1 A novel polypeptide, a atp-dependant human rna helicase 11 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096525A2 A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096397A2 Cd154 variants and uses thereof |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096385A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | WO2001096360A1 Antisense modulation of c/ebp beta expression |
| 12/20/2001 | WO2001096345A1 Tetrapyrroles |
| 12/20/2001 | WO2001096322A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | WO2001096318A1 Cyclic urea compounds and preparation thereof |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096300A1 Growth hormone secretagogues |
| 12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
| 12/20/2001 | WO2001095935A1 Immunostimulatory nucleic acids for inducing a th2 immune response |
| 12/20/2001 | WO2001095934A2 The use of plant oil-bodies in vaccine delivery systems |
| 12/20/2001 | WO2001095929A2 Interferon for treatment of multiple sclerosis |
| 12/20/2001 | WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 12/20/2001 | WO2001095926A1 Immunosuppressor agent derived from morbillivirus |
| 12/20/2001 | WO2001095925A1 Pharmaceutical anti-inflammatory aerosol formulation |
| 12/20/2001 | WO2001095921A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001095914A1 Lipids for modulating immune response |
| 12/20/2001 | WO2001095890A2 Oral pharmaceutical compositions containing terbinafine |
| 12/20/2001 | WO2001095882A1 Novel aqueous anti-inflammatory pharmaceutical formulation |
| 12/20/2001 | WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds |
| 12/20/2001 | WO2001095785A2 Modulation of immune response and methods based thereon |
| 12/20/2001 | WO2001095710A1 Caspase 1 gene transfer animal |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001079259A8 Javelinization of protein antigens to heat shock proteins |
| 12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
| 12/20/2001 | WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 12/20/2001 | WO2001052888A3 Improved dna vaccines for production-type animals |
| 12/20/2001 | WO2001052874A3 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 12/20/2001 | WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001024822A3 Pharmaceutical composition comprising an antigen |
| 12/20/2001 | US20010053782 Pyrrolo[2,3-d]pyrimidine compounds |
| 12/20/2001 | US20010053768 Gene therapy using replication competent targeted adenoviral vectors |
| 12/20/2001 | US20010053763 Method and composition for modulating an immune response |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors |
| 12/20/2001 | US20010053362 Tolerizing the immune system of a non-human animal with antigens from said subject, and thereafter transplanting the bone marrow of said subject with the bone marrow of said tolerized immune system. |
| 12/20/2001 | US20010053361 Immunotherapy involving cd28 stimulation |
| 12/20/2001 | US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct. |
| 12/20/2001 | US20010053355 Treated monocytes incubated to maximize number of functional dendritic cells; then incubated with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents. |
| 12/20/2001 | US20010053351 Inhibition of GSK-3 beta |
| 12/20/2001 | DE10128250A1 New hydrolytically stable glycolipid compounds having an alpha-C, N or S glycoside bond, useful as anticancer agents and immunostimulants |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | CA2778314A1 Cyclic urea compounds and preparation thereof |
| 12/20/2001 | CA2413077A1 Interferon for treatment of multiple sclerosis |
| 12/20/2001 | CA2412623A1 Tetrapyrroles |
| 12/20/2001 | CA2412356A1 Immunosuppressor agent derived from morbillivirus |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2411965A1 The use of plant oil-bodies in vaccine delivery systems |
| 12/20/2001 | CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion |
| 12/20/2001 | CA2411472A1 Cd154 variants |
| 12/20/2001 | CA2411231A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | CA2410824A1 Diamino phenothiazine derivatives and composition comprising same |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof |
| 12/20/2001 | CA2409315A1 Protein phosphatases |
| 12/20/2001 | CA2396871A1 Immunostimulatory nucleic acids for inducing a th2 immune response |
| 12/19/2001 | EP1164133A2 Enantiomerically pure Beta-D-(-)-dioxolane-nucleosides |
| 12/19/2001 | EP1163909A2 Use of sugar ethers as immunity adjuvant in vaccine compositions, therapeutic compositions containing them and their use as vaccine |
| 12/19/2001 | EP1163902A2 Transdermal preparation containing hydrophilic or salt-form drug |
| 12/19/2001 | EP1163524A2 Methods of screening for colorectal cancer modulators |
| 12/19/2001 | EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression |
| 12/19/2001 | EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
| 12/19/2001 | EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 12/19/2001 | EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells |
| 12/19/2001 | EP1163332A1 48 human secreted proteins |